Michel Hebraud
Overview
Explore the profile of Michel Hebraud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1995
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kavanaugh D, Sivignon A, Rossez Y, Chouit Z, Chambon C, Beal L, et al.
Front Microbiol
. 2025 Feb;
16:1507286.
PMID: 39973929
The surfaceome consists mainly of the large surface organelles expressed by the organism to navigate and interact with the surrounding environment. The current study focuses on type I fimbriae and...
2.
de Sousa T, Silva C, Igrejas G, Hebraud M, Poeta P
J Basic Microbiol
. 2025 Feb;
:e70004.
PMID: 39972634
Pseudomonas aeruginosa is an opportunistic bacterium widely distributed in both natural and urban environments, playing a crucial role in global microbial ecology. This article reviews the interactive dynamics of P....
3.
Pseudomonas aeruginosa: One Health approach to deciphering hidden relationships in Northern Portugal
de Sousa T, Machado S, Canica M, Ramos M, Santos D, Ribeiro M, et al.
J Appl Microbiol
. 2025 Feb;
136(2).
PMID: 39947205
Aims: Antimicrobial resistance in Pseudomonas aeruginosa represents a major global challenge in public and veterinary health, particularly from a One Health perspective. This study aimed to investigate antimicrobial resistance, the...
4.
de Sousa T, Carvalho M, Beyrouthy R, Bonnet R, Martins A, Hebraud M, et al.
Microb Pathog
. 2024 Sep;
196:106932.
PMID: 39303957
Pseudomonas aeruginosa demonstrates a remarkable capacity for adaptation and survival in diverse environments. Furthermore, its clinical importance is underscored by its intrinsic and acquired resistance to a wide range of...
5.
de Sousa T, Sabenca C, Ribeiro M, Pino-Hurtado M, Torres C, Hebraud M, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540251
and are notorious for their resistance to antibiotics and propensity for biofilm formation, posing significant threats to human health. Epsilon-poly-L-lysine (ε-PL) emerges as a naturally occurring antimicrobial poly(amino acid), which...
6.
de Sousa T, Silva C, Alves O, Costa E, Igrejas G, Poeta P, et al.
Microorganisms
. 2023 Nov;
11(11).
PMID: 38004699
is among the most ubiquitous bacteria in the natural world, exhibiting metabolic and physiological versatility, which makes it highly adaptable. Imipenem + cilastatin and tetracycline are antibiotic combinations commonly used...
7.
Monteiro R, Chafsey I, Caccia N, Ageorges V, Leroy S, Viala D, et al.
Cells
. 2023 Jun;
12(12).
PMID: 37371104
is a versatile commensal species of the animal gut that can also be a pathogen able to cause intestinal and extraintestinal infections. The plasticity of its genome has led to...
8.
de Sousa T, Hebraud M, Alves O, Costa E, Maltez L, Pereira J, et al.
Microorganisms
. 2023 Jun;
11(5).
PMID: 37317319
causes urinary tract infections associated with catheters by forming biofilms on the surface of indwelling catheters. Therefore, controlling the spread of the bacteria is crucial to preventing its transmission in...
9.
Paris L, Devers-Lamrani M, Joly M, Viala D, Antonio M, Pereira B, et al.
FEMS Microbiol Ecol
. 2023 Jun;
99(7).
PMID: 37309049
Microbacterium sp. C448, isolated from a soil regularly exposed to sulfamethazine (SMZ), can use various sulphonamide antibiotics as the sole carbon source for growth. The basis for the regulation of...
10.
de Sousa T, Garces A, Silva A, Lopes R, Alegria N, Hebraud M, et al.
Vet Sci
. 2023 May;
10(5).
PMID: 37235426
is a pathogenic bacterium that can cause serious infections in both humans and animals, including dogs. Treatment of this bacterium is challenging because some strains have developed multi-drug resistance. This...